Form 4 for SPRB SPRUCE BIOSCIENCES, INC.
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-10 · accession 0001533302-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | M - OptEx | $0.00 | +2,414 | 8,296 | +41% | $0 |
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | F - Tax | $87.83 | -864 | 7,616 | -10% | -$75.9K |
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | M - OptEx | $0.00 | -2,414 | 5,700 | -30% | $0 |
| D | 2025-12-12 | 2025-12-11 | SPRB | Gharib Samir M. | Pres AND CFO | A - Grant | $0.00 | +7,600 | 7,600 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-10 | M | A | 514 | $0.00 | 6,580 | D | — | — | (F1) On March 14, 2024, the Reporting Person was granted a total of 2,053 RSU's. Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective. 25% of the total number of the RSUs will vest on each of the second, third and fourth anniversaries of such achievement. On December 10, 2025, 514 shares vested and 184 shares were withheld for taxes, resulting in a net issuance of 330 shares. (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. |
| 2 | Common | Common Stock | 2025-12-10 | F | D | 184 | $85.67 | 6,396 | D | — | — | (F1) On March 14, 2024, the Reporting Person was granted a total of 2,053 RSU's. Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective. 25% of the total number of the RSUs will vest on each of the second, third and fourth anniversaries of such achievement. On December 10, 2025, 514 shares vested and 184 shares were withheld for taxes, resulting in a net issuance of 330 shares. |
| 3 | Common | Common Stock | 2025-12-11 | M | A | 1,900 | $0.00 | 8,296 | D | — | — | (F3) 25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 1,900 shares vested and 680 shares were withheld for taxes, resulting in a net issuance of 1,220 shares. (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. |
| 4 | Common | Common Stock | 2025-12-11 | F | D | 680 | $88.41 | 7,616 | D | — | — | (F3) 25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 1,900 shares vested and 680 shares were withheld for taxes, resulting in a net issuance of 1,220 shares. |
| 5 | Derivative | Restricted Stock Units | 2025-12-10 | M | D | 514 | $0.00 | 1,539 | D | $0.00 · — to — | 514 Common Stock | (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. (F1) On March 14, 2024, the Reporting Person was granted a total of 2,053 RSU's. Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective. 25% of the total number of the RSUs will vest on each of the second, third and fourth anniversaries of such achievement. On December 10, 2025, 514 shares vested and 184 shares were withheld for taxes, resulting in a net issuance of 330 shares. |
| 6 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 1,900 | $0.00 | 5,700 | D | $0.00 · — to — | 1,900 Common Stock | (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. (F3) 25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 1,900 shares vested and 680 shares were withheld for taxes, resulting in a net issuance of 1,220 shares. |
| 7 | Derivative | Restricted Stock Units | 2025-12-11 | A | A | 7,600 | $0.00 | 7,600 | D | $0.00 · — to — | 7,600 Common Stock | (F2) Each RSU represents a contingent right to receive one share of SPRB common stock. (F3) 25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 1,900 shares vested and 680 shares were withheld for taxes, resulting in a net issuance of 1,220 shares. |